Investment supports platform innovation, commercial scaling, and new service development; Infinity acquires the assets of Serimmune, Inc.
Read More
Resources
News
Stay current with our recent news, updates, and announcements.
Now available – completely unbiased, high throughput analysis of antibody binding to the complete mouse proteome with MuSIGHT™
Read More
Ben Larman, Scientific Founder and Chief Scientific Officer (CSO) of Infinity Bio, is driven by a passion for advancing human health by decoding the complexities of the immune system. We discuss Ben’s Antibody Reactomics Framework and his Complex Data Delivery Framework.
Read More
Advisory Board to guide Infinity Bio's research strategy, driving innovation in disease diagnostics and therapeutic advancements.
Read More
Infinity Bio is proud to announce that we’ve been awarded a prestigious Gold MarCom Award for our website. This recognition highlights our commitment to not only advancing scientific innovation but also ensuring that our digital presence reflects the cutting-edge work we do in antibody profiling. Our newly designed website was crafted to enhance the user experience, making it easier for our visitors to explore our mission and innovations. We’re honored to be recognized by MarCom for excellence in web design and communication.
Read More
New service leverages proprietary technology to provide unprecedented insights into antibody autoreactivity for translational research and therapeutic development.
Read More
Infinity Bio, Inc. is proud to announce its selection by the TEDDY (The Environmental Determinants of Diabetes in the Young) study to provide comprehensive antibody reactome services for their large cohort. This collaboration marks a significant milestone for Infinity Bio as it continues to advance its mission to deliver cutting-edge immunological insights and solutions.
Read More
Infinity Bio, Inc., a biotechnology company specializing in antibody reactome profiling, hosted a special community event aimed at engaging and inspiring Baltimore children with an interest in STEM. The event took place on July 22, 2024, at Infinity Bio’s office and laboratory at 6200 Seaforth Street, Baltimore, MD, and featured various activities designed to spark interest in science and technology.
Read More
Infinity Bio, a technology company known for its innovative antibody reactome profiling service, will host an open house event at its state-of-the-art laboratory at 6200 Seaforth Street in Baltimore on July 23, 2024. This event is designed to give members of the local scientific and biotech community an exclusive look at the research and technologies that are driving developments in immunology.
Read More
Infinity Bio takes a business-to-business approach to pharmaceuticals. Here's more on the company and its growth.
Read More